Bora Pharmaceuticals Announces Unveiling of New Multi-Purpose Small Molecule Site in Zhongli, Taiwan Taipei, Taiwan (January 6, 2025) – Bora Pharmaceuticals Co., Ltd. (“Bora,” TWSE: 6472), a global cGMP contract development and manufacturing organization (CDMO), is pleased to announce the grand unveiling of its new small molecule dose form facility in Zhongli, Taiwan. This represents another...
